Literature DB >> 21138693

[Effects of different anesthesia and analgesia on erythrocyte immune function of patients with ovarian benign tumor treated by laparoscopic therapeutic].

Jian-Fei Zou1, Jian-Yu Li, Xin-Wen Wu, Shao-Yang Chen.   

Abstract

AIM: To investigate the effects of different anesthesia and analgesia on erythrocyte immune function of patients with ovarian benign tumor treated by laparoscopic therapeutic.
METHODS: 120 patients with ovarian benign tumor treated by laparoscopic therapeutic were randomly divided into two groups with 60 cases each.In group A, patients received general anesthesia eombined with thoracic epidural anesthesia during surgery, patients in group B received general anesthesia. The cervical venous blood samples were obtained at the following time points: before induction of anesthesia(T0), 30 min after anesthesia (T1), 1 h during operation (T2), 24 h after operation (T3), 48 h after operation (T4) and 72 h after operation (T5).RRCR, RRICR and RTRR were measured at different time points.
RESULTS: RRCR, RRICR and RTRR in two groups decreased significantly from T1(P<0.05). RRCR in two groups was on the low-water mark at T4 and RRICR, RTRR was on the low-water mark at T3.There were no significantly different of RRCR, RRICR and RTRR in two groups at T0. There were significantly different of RRCR, RRICR and RTRR in two groups from T1 to T4(P<0.05), the increase in group A was less than that in group B(P<0.05).
CONCLUSION: Anesthesia may harm on erythroeyte immune function of patients with ovarian benign tumor treated by laparoscopic therapeutic. The effect of general anesthesia combined with thoraeic epidural anesthesia on erythrocyte immune function was less.

Entities:  

Mesh:

Year:  2010        PMID: 21138693

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  7 in total

1.  Combined general and regional anesthesia and effects on immune function in patients with benign ovarian tumors treated by laparoscopic therapy.

Authors:  Yong-Chong Cheng; Xiao-Bin Cheng; Xin-Jie Li; Feng-Zhao Wang; Zhi-Kui Li
Journal:  Int J Clin Exp Med       Date:  2013-09-01

Review 2.  Acupuncture for pain caused by prostate cancer: Protocol for a systematic review.

Authors:  Jisheng Wang; Yi Lei; Binghao Bao; Xudong Yu; Hengheng Dai; Fei Chen; Haisong Li; Bin Wang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

3.  Traditional Chinese medicine on treating pain caused by prostate cancer: A systematic review and meta-analysis.

Authors:  Ning Wang; Li Xu; Ji-Sheng Wang; Xu-Dong Yu; Li-Yuan Chu; Sheng Deng; Fu-Xing Ge; Hai-Song Li
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

4.  Assessment of the efficacy of Chinese patent medicine on treating pain caused by prostate cancer: A protocol for systematic review and meta analysis.

Authors:  Xiaoyong Gong; Ji-Sheng Wang; Xu-Dong Yu; Rui-Jia Liu; Li-Yuan Chu; Yuan-Yuan Li; Yi Lei; Hong Li
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

5.  Effects of oxycodone on immune function in patients undergoing radical resection of rectal cancer under general anesthesia.

Authors:  Jia-Hua Cui; Wan-Wei Jiang; Ya-Jing Liao; Qing-Hui Wang; Min Xu; Yu Li
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

6.  Effect of different anesthetic methods on cellular immune functioning and the prognosis of patients with ovarian cancer undergoing oophorectomy.

Authors:  Xin-Rui Han; Xin Wen; Yan-Yi Li; Shao-Hua Fan; Zi-Feng Zhang; Hong Li; Xing-Feng Sun; Gui-Qi Geng; Shen Sun; Shao-Qiang Huang; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  Biosci Rep       Date:  2017-10-24       Impact factor: 3.976

7.  A randomized controlled trial for acupuncture combined with conventional therapy in the treatment of pain caused by prostate cancer: Study protocol clinical trial (SPIRIT compliant).

Authors:  Yi Lei; Yunyun Duan; Jisheng Wang; Xudong Yu; Sheng Deng; Ruijia Liu; Hongmei Si; Jiameng Li; Bao Zhang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.